Skip to main content
MDA
NYSE Manufacturing

MDA Space Q3 Revenue Up 21.5% to C$498M, Raises 2026 Revenue and EBITDA Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Aerospace & Defense Stocks · Industrial
Sentiment info
Positive
Importance info
8
Price
$29.3
Mkt Cap
$4.253B
52W Low
$15
52W High
$49.37
52W Position info
95% above low
Off High info
41% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

MDA sits 95% above its 52-week low of $15.

Summary

MDA Space posted Q3 2026 revenue of C$498.1 million (+21.5% YoY) and adjusted EBITDA of C$96.0 million, and raised its 2026 revenue and adjusted EBITDA guidance. The company ended the quarter with C$2.15 billion of cash to fund its pending Blue Canyon and CLS acquisitions.


Key Events · Earnings and Guidance · MDA

  • Q3 Revenue Grows 21.5%

    Revenue of C$498.1 million versus C$409.8 million a year earlier, driven by Satellite Systems (+26.4% to C$358.3 million) and Geointelligence (+24.8% to C$59.9 million).

  • 2026 Guidance Raised

    Revenue outlook lifted to C$1.90-C$1.95 billion from C$1.8-C$1.9 billion, and adjusted EBITDA to C$355-C$375 million from C$330-C$370 million; 18%-20% margin guidance reaffirmed.

  • Margin Slips on Mix and SG&A

    Adjusted EBITDA rose 15.9% to C$96.0 million but margin fell to 19.3% from 20.2% on program mix and higher selling, general and administrative spend.

  • Balance Sheet Funded for Acquisitions

    Cash of C$2,153.8 million and long-term debt of C$825.8 million at September 30, 2026 leave a net cash position of C$1,328.0 million to fund the pending Blue Canyon and CLS deals.


Analysis · MDA · Manufacturing

MDA Space grew Q3 revenue 21.5% to C$498.1 million and lifted adjusted EBITDA 15.9% to C$96.0 million, then raised full-year revenue guidance to C$1.90-C$1.95 billion and adjusted EBITDA to C$355-C$375 million. The quarter also brought a C$474 million Telesat contract expansion and a post-quarter IRIS² authorization to proceed worth more than C$100 million. With C$2.15 billion of cash and a net cash position of C$1.33 billion, the balance sheet is funded for the pending Blue Canyon and CLS acquisitions. The one blemish is margin: adjusted EBITDA margin slipped to 19.3% from 20.2% on program mix and higher SG&A, and backlog eased to C$3.9 billion from C$4.4 billion a year ago.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MDA was trading at $29.30 on NYSE in the Manufacturing sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $15.00 to $49.37. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MDA - Latest Insights

MDA
Nov 05, 2026, 5:45 AM EST
Source: PR Newswire
Importance Score:
8
Price at Filing: $27.60
Real-time Price: $28.66 info
Change: +$1.06 (+4%) info
Market Cap: $4.521B info
MDA
Nov 04, 2026, 4:00 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $26.21
Real-time Price: $28.66 info
Change: +$2.45 (+9%) info
Market Cap: $4.521B info
MDA
Oct 14, 2026, 6:01 AM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $28.00
Real-time Price: $28.66 info
Change: +$0.660 (+2%) info
Market Cap: $4.521B info
MDA
Aug 07, 2026, 8:23 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $34.60
Real-time Price: $28.66 info
Change: -$5.94 (-17%) info
Market Cap: $4.521B info
MDA
Aug 07, 2026, 8:22 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $34.60
Real-time Price: $28.66 info
Change: -$5.94 (-17%) info
Market Cap: $4.521B info